Over the span of a century, epochal changes have occurred and in the last year there have been equally significant changes.

One hundred years after the discovery of insulin, the life-saving drug that changed the history of diabetes, diabetes is called around the world to respond to the new challenges imposed by clinical and therapeutic innovation and the Covid-19 pandemic.

When, in 1921, Dr. Frederick Grant Banting and his student and assistant, Charles Herbert Best, discovered how to extract insulin, diabetes was still a deadly disease and life expectancy was very short. Today the scenario has completely changed and the quality of diabetes care is still, after this first century of diabetes, in continuous improvement. New inulin formulations and new technological innovations without needles such as Comfort-in, non-invasive and revolutionary for the well-being of the diabetic person.

Needleless devices not only mean more comfort, but also more safety for the patient, especially today with the arrival of the Covid-19 pandemic and the simultaneous presence of other viruses and pathogens with which we will probably have to live in the coming years.

Of course, the patient will also have a different role, increasingly called to be involved in the process of care and assistance and increasingly aware and autonomous in adopting more confident solutions in science and more innovative.